Kangji Medical Holdings Limited
SZSC:9997 Rapporto sulle azioni
Kangji Medical Holdings Salute del bilancio
Salute finanziaria criteri di controllo 6/6 Kangji Medical Holdings ha un patrimonio netto totale di CN¥2.4B e un debito totale di CN¥0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥4.4B e CN¥2.0B. L'EBIT di Kangji Medical Holdings è CN¥491.1M rendendo il suo rapporto di copertura degli interessi -4.5. Ha liquidità e investimenti a breve termine pari a CN¥2.8B.
Informazioni chiave
0%
Rapporto debito/patrimonio netto
Indice di copertura degli interessi -4.5x Contanti CN¥2.78b Patrimonio netto CN¥2.36b Totale passività CN¥2.00b Totale attività CN¥4.36b
Aggiornamenti recenti sulla salute finanziaria
Mostra tutti gli aggiornamenti
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Sep 27
First half 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.22 in 1H 2023) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2024 Results on Aug 20, 2024 Aug 06 Kangji Medical Holdings Limited Approves Special Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024
Investor sentiment deteriorates as stock falls 26% May 29
Upcoming dividend of CN¥1.40 per share May 22
Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.40 in FY 2022) Apr 30
Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023 Apr 26
Dividend of CN¥1.40 announced Mar 22 Kangji Medical Holdings Limited, Annual General Meeting, May 27, 2024
Investor sentiment improves as stock rises 17% Nov 08
Kangji Medical Holdings Limited Announces CFO Changes Sep 06 Kangji Medical Holdings Limited Announces the Resignation of Frances Fang Chovanec as Executive Director, Member of Environmental, Social and Governance Committee with Effective from September 15, 2023
First half 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1H 2022) Aug 31
Kangji Medical Holdings Limited to Report First Half, 2023 Results on Aug 29, 2023 Aug 09
Now 21% undervalued after recent price drop Aug 01
Now 22% undervalued after recent price drop Jul 05
Now 20% undervalued after recent price drop Jun 12
Kangji Medical Holdings Limited Approves Payment of Final Dividend for the Year Ended December 31, 2022, Payment Date Is 10 July 2023 May 26
Full year 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.37 in FY 2021) Mar 29
Investor sentiment improved over the past week Jan 16
Less than half of directors are independent Nov 16
First half 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.16 in 1H 2021) Aug 26
Kangji Medical Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022 Aug 03
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021, Payment date is 08 July 2022 May 27
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021 May 26
Upcoming dividend of HK$0.17 per share May 20
Kangji Medical Holdings Limited Announces Executive Changes May 04
Full year 2021 earnings released: EPS: CN¥0.37 (vs CN¥0.26 in FY 2020) May 03
Less than half of directors are independent Apr 27
Kangji Medical Holdings Limited to Report Fiscal Year 2021 Results on Mar 22, 2022 Mar 03
Investor sentiment deteriorated over the past week Dec 07
Investor sentiment improved over the past week Sep 02
First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.12 in 1H 2020) Aug 29
Investor sentiment improved over the past week Aug 03
Investor sentiment improved over the past week Jul 16
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2020 May 27
Investor sentiment improved over the past week May 17
Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.20 in FY 2019) Apr 28
Kangji Medical Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2020 Apr 27
Investor sentiment improved over the past week Apr 24
Full year 2020 earnings released Mar 26
Kangji Medical Holdings Limited to Report Fiscal Year 2020 Results on Mar 25, 2021 Mar 13
Investor sentiment deteriorated over the past week Feb 27
New 90-day low: HK$10.88 Feb 27
Investor sentiment deteriorated over the past week Jan 29
New 90-day low: HK$12.16 Jan 28
Investor sentiment deteriorated over the past week Dec 24
New 90-day low: HK$13.86 Dec 09
Market pulls back on stock over the past week Nov 26
Kangji Medical Holdings Limited Appoints Frances Fang Chovanec as Executive Director Nov 06
First half earnings released Sep 22
Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( CN¥3.6B ) di 9997 superano le sue passività a breve termine ( CN¥2.0B ).
Passività a lungo termine: Le attività a breve termine di 9997 ( CN¥3.6B ) superano le sue passività a lungo termine ( CN¥19.1M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 9997 è esente da debiti.
Riduzione del debito: 9997 non ha avuto debiti negli ultimi 5 anni.
Copertura del debito: 9997 non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo .
Copertura degli interessi: 9997 non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}